Følg
Warren Mason
Warren Mason
Princess Margaret Cancer Centre, University of Toronto
Verifisert e-postadresse på uhn.ca - Startside
Tittel
Sitert av
Sitert av
År
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp, WP Mason, MJ Van Den Bent, M Weller, B Fisher, ...
New England journal of medicine 352 (10), 987-996, 2005
199422005
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...
New England Journal of Medicine 352 (10), 997-1003, 2005
75812005
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
71932009
Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma
J Dalmau, E Tüzün, H Wu, J Masjuan, JE Rossi, A Voloschin, ...
Annals of neurology 61 (1), 25-36, 2007
27552007
Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma
OL Chinot, W Wick, W Mason, R Henriksson, F Saran, R Nishikawa, ...
New England Journal of Medicine 370 (8), 709-722, 2014
23402014
European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and …
R Stupp, WP Mason, MJ Van den Bent, M Weller, B Fisher, MJ Taphoorn, ...
N Engl J Med 352 (10), 987-996, 2005
933*2005
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of …
R Stupp, ME Hegi, WP Mason, MJ van den Bent, MJ Taphoorn, ...
Lancet Oncol 10 (5), 459-466, 2009
9092009
Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ...
New England Journal of Medicine 376 (11), 1027-1037, 2017
7782017
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
R Vitaliani, W Mason, B Ances, T Zwerdling, Z Jiang, J Dalmau
Annals of Neurology: Official Journal of the American Neurological …, 2005
7482005
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ...
J Clin Oncol 24 (16), 2563-2569, 2006
5982006
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of …
M Petit-Pedrol, T Armangue, X Peng, L Bataller, T Cellucci, R Davis, ...
The Lancet Neurology 13 (3), 276-286, 2014
5652014
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
TT Batchelor, P Mulholland, B Neyns, LB Nabors, M Campone, A Wick, ...
Journal of Clinical Oncology 31 (26), 3212, 2013
5262013
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma
W Wick, VK Puduvalli, MC Chamberlain, MJ Van Den Bent, AF Carpentier, ...
Journal of clinical oncology 28 (7), 1168, 2010
5232010
Changing paradigms—an update on the multidisciplinary management of malignant glioma
R Stupp, ME Hegi, MJ Van Den Bent, WP Mason, M Weller, ...
The oncologist 11 (2), 165-180, 2006
4782006
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ...
Journal of Clinical Oncology 15 (8), 2866-2872, 1997
4281997
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ...
The Lancet Oncology 17 (11), 1521-1532, 2016
4182016
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study
JR Perry, K Bélanger, WP Mason, D Fulton, P Kavan, J Easaw, C Shields, ...
J Clin Oncol 28 (12), 2051-2057, 2010
3992010
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
WP Mason, F Graus, B Lang, J Honnorat, JY Delattre, F Valldeoriola, ...
Brain: a journal of neurology 120 (8), 1279-1300, 1997
3721997
Health-related quality of life in patients with glioblastoma: a randomised controlled trial
MJB Taphoorn, R Stupp, C Coens, D Osoba, R Kortmann, ...
The lancet oncology 6 (12), 937-944, 2005
3492005
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 …
MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ...
The Lancet 390 (10103), 1645-1653, 2017
3252017
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20